Author

Raisa Munira

City University of New York

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

Pooja Prakash RaoiD· 2 shared Shahana S. MahajaniD· 2 shared Syeda Maryam AzeemiD· 2 shared Adriana Haimovitz‐FriedmaniD· 1 shared Charis Herbert· 1 shared Elena Gary· 1 shared Gloria Ho· 1 shared Hadi Askarifirouzja· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Pooja Prakash RaoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 15, 2025

EGR1 Mediates Riluzole-Induced Apoptosis in Osteosarcoma via the Yap/p73-Bax Signaling Axis

Syeda Maryam Azeem, Shraddha ChandThakuri, Pooja Prakash Rao…·Shahana S. Mahajan

This study shows Riluzole induces apoptosis in osteosarcoma by upregulating EGR1, which interacts with Yap/p73 to enhance Bax expression and promote cell death.

DOI 10.1101/2025.10.15.682608

humanproteomics

𝕏 PostBluesky

Cancer BiologyInternational Journal of Radiation Oncology*Biology*PhysicsPeer-reviewedSep 1, 2025

Riluzole as a Dual-Targeted Radiosensitizer for Osteosarcoma: Targeting Tumor Cells and Angiogenic Vasculature to Enhance Single High Dose Radiotherapy Efficacy

Pooja Prakash Rao, Charis Herbert, Syeda Maryam Azeem…·Shahana S. Mahajan

This paper demonstrates that Riluzole enhances osteosarcoma radiosensitivity to single high dose radiotherapy by targeting both tumor cells and angiogenic vasculature.

DOI 10.1016/j.ijrobp.2025.06.3486

humanexperimental assay

𝕏 PostBluesky